Invention Grant
- Patent Title: Piperidine CXCR7 receptor modulators
-
Application No.: US16928787Application Date: 2020-07-14
-
Publication No.: US11306078B2Publication Date: 2022-04-19
- Inventor: Hamed Aissaoui , Philippe Guerry , Francois Lehembre , Julien Pothier , Laetitia Pouzol , Sylvia Richard-Bildstein , Shuguang Yuan
- Applicant: IDORSIA PHARMACEUTICALS LTD.
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee Address: CH Allschwil
- Agency: Culhane Meadow, PLLC
- Agent Jeff B. Vockrodt
- Priority: WOPCT/EP2016/068052 20160728
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D413/12 ; C07D401/12 ; C07D401/14 ; C07D417/14 ; A61P35/00
Abstract:
The present invention relates to piperidine derivatives of formula (I) wherein Ar1, Ar2, RAr1, R1, R2, and R3 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
Information query
